MAT
Medication-assisted treatment (MAT) has emerged as what clinicians are calling the “gold standard of addiction care.” Combined with medical detoxification and withdrawal management, as well as comprehensive behavioral therapy, MAT can exponentially increase patients’ odds of long-term recovery, specifically from alcohol and opioid abuse. There is ample evidence that the use of medication-assisted treatment (MAT), reduced the number of heroin deaths significantly, specifically when buprenorphine was made more accessible to patients. Additionally, the American Society of Addiction medicine has wholeheartedly endorsed these interventions, saying that they are an effective long-term means of care. As a cornerstone of our care offerings, iRecovery provides comprehensive, medication-assisted treatment (MAT) to all those who are suffering from alcohol and opioid use disorder. MAT has been established and offered for opioid use disorder, alcohol addiction and cigarette smoking. We offer services for these conditions. Medications that are most commonly associated with the medication-assisted treatment (MAT) process include:
- Suboxone® (buprenorphine and naloxone)
- Vivitrol® (monthly injectable naltrexone)
- Sublocade® (extended-related injectable buprenorphine)